Your session is about to expire
← Back to Search
Topical Calcipotriene for Breast Cancer
Study Summary
This trial is testing a topical ointment to see if it can stop breast lesions from recurring after surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman over 45 and have gone through menopause.I have a non-invasive or early-stage breast cancer and will have surgery without prior chemotherapy.My cancer is hormone receptor positive, HER2 positive, or triple negative.I had breast cancer within the last 5 years.I am immunosuppressed due to an organ transplant or autoimmune disease treatment.I have had high calcium levels or vitamin D toxicity in the past.I haven't had chemotherapy or radiotherapy in the last 4 weeks, or 6 weeks for specific drugs, and have recovered from any side effects.I have multiple tumors in one or more areas.My breast biopsy showed non-cancerous or early cancer cells, and I'm going straight to surgery without chemo first.I am not pregnant or a premenopausal woman.I do not have brain metastases.I am allergic to ingredients similar to those in calcipotriene ointment.I am scheduled for initial treatment before surgery for breast cancer.My breast cancer has spread to other parts of my body.
- Group 1: Topical Vaseline
- Group 2: Topical Calcipotriene Ointment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please elucidate on what research has been conducted utilizing Topical Calcipotriene Ointment?
"Presently, there are 7 open clinical trials for Topical Calcipotriene Ointment with 1 study in its last phase. Primarily based out of Boston, Massachusetts, these medical studies have a presence at 65 different locations throughout the country."
To what extent is enrollment for this trial increasing?
"Affirmative, as indicated on clinicaltrials.gov the trial is still recruiting participants. It was initially posted in November of 2018 and most recently updated in November 2021 with a goal to enroll 120 patients at one medical site."
Are there still available spots for participants in this research endeavor?
"Confirmed, according to clinicaltrials.gov, this research trial is still open for volunteers and was initially posted on the 7th of November 2018 with updates made as recently as 2nd November 2021."
What possible risks accompany utilization of Topical Calcipotriene Ointment?
"Due to limited data, this topical ointment's safety was rated as a 1 on our team at Power's scale of 1-3. This is because the trial is in Phase 1, with little evidence supporting its efficacy and safeguards."
Share this study with friends
Copy Link
Messenger